Cargando…

Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center

Detalles Bibliográficos
Autores principales: Stephens, Deborah M., Ruppert, Amy S., Jones, Jeffrey, Woyach, Jennifer, Maddocks, Kami, Jaglowski, Samantha, Andritsos, Leslie A., Flynn, Joseph M., Grever, Michael R., Lozanski, Gerard, Johnson, Amy J., Muthusamy, Natarajan, Heerema, Nyla A., Byrd, John C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047185/
https://www.ncbi.nlm.nih.gov/pubmed/24451411
http://dx.doi.org/10.1038/leu.2014.42
_version_ 1782480373616214016
author Stephens, Deborah M.
Ruppert, Amy S.
Jones, Jeffrey
Woyach, Jennifer
Maddocks, Kami
Jaglowski, Samantha
Andritsos, Leslie A.
Flynn, Joseph M.
Grever, Michael R.
Lozanski, Gerard
Johnson, Amy J.
Muthusamy, Natarajan
Heerema, Nyla A.
Byrd, John C.
author_facet Stephens, Deborah M.
Ruppert, Amy S.
Jones, Jeffrey
Woyach, Jennifer
Maddocks, Kami
Jaglowski, Samantha
Andritsos, Leslie A.
Flynn, Joseph M.
Grever, Michael R.
Lozanski, Gerard
Johnson, Amy J.
Muthusamy, Natarajan
Heerema, Nyla A.
Byrd, John C.
author_sort Stephens, Deborah M.
collection PubMed
description
format Online
Article
Text
id pubmed-4047185
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-40471852014-12-01 Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center Stephens, Deborah M. Ruppert, Amy S. Jones, Jeffrey Woyach, Jennifer Maddocks, Kami Jaglowski, Samantha Andritsos, Leslie A. Flynn, Joseph M. Grever, Michael R. Lozanski, Gerard Johnson, Amy J. Muthusamy, Natarajan Heerema, Nyla A. Byrd, John C. Leukemia Article 2014-01-23 2014-06 /pmc/articles/PMC4047185/ /pubmed/24451411 http://dx.doi.org/10.1038/leu.2014.42 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Stephens, Deborah M.
Ruppert, Amy S.
Jones, Jeffrey
Woyach, Jennifer
Maddocks, Kami
Jaglowski, Samantha
Andritsos, Leslie A.
Flynn, Joseph M.
Grever, Michael R.
Lozanski, Gerard
Johnson, Amy J.
Muthusamy, Natarajan
Heerema, Nyla A.
Byrd, John C.
Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center
title Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center
title_full Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center
title_fullStr Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center
title_full_unstemmed Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center
title_short Impact of Targeted Therapy on Outcome of Chronic Lymphocytic Leukemia Patients with Relapsed Del(17p13.1) Karyotype at a Single Center
title_sort impact of targeted therapy on outcome of chronic lymphocytic leukemia patients with relapsed del(17p13.1) karyotype at a single center
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047185/
https://www.ncbi.nlm.nih.gov/pubmed/24451411
http://dx.doi.org/10.1038/leu.2014.42
work_keys_str_mv AT stephensdeborahm impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT ruppertamys impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT jonesjeffrey impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT woyachjennifer impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT maddockskami impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT jaglowskisamantha impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT andritsoslesliea impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT flynnjosephm impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT grevermichaelr impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT lozanskigerard impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT johnsonamyj impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT muthusamynatarajan impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT heeremanylaa impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter
AT byrdjohnc impactoftargetedtherapyonoutcomeofchroniclymphocyticleukemiapatientswithrelapseddel17p131karyotypeatasinglecenter